scispace - formally typeset
H

Hiroyuki Terawaki

Researcher at Fukushima Medical University

Publications -  59
Citations -  958

Hiroyuki Terawaki is an academic researcher from Fukushima Medical University. The author has contributed to research in topics: Renal function & Kidney disease. The author has an hindex of 16, co-authored 55 publications receiving 849 citations. Previous affiliations of Hiroyuki Terawaki include Jikei University School of Medicine.

Papers
More filters
Journal ArticleDOI

Oxidative stress is enhanced in correlation with renal dysfunction: Examination with the redox state of albumin

TL;DR: Investigating the current status of oxidative stress in predialysis patients with renal failure found that even before dialysis, oxidative stress was enhanced in correlation with the level of renal dysfunction among patients with chronic renal failure.
Journal ArticleDOI

Plasma α-Oxoaldehyde Levels in Diabetic and Nondiabetic Chronic Kidney Disease Patients

TL;DR: Plasma GO and MG levels increase as the CKD stages progress and high plasma MG levels may be associated with an increased risk of CVD in CKD patients.
Journal ArticleDOI

Renoprotective effects of febuxostat in hyperuricemic patients with chronic kidney disease: a parallel-group, randomized, controlled trial

TL;DR: Whether febuxostat prevents the progression of renal disease and improves the prognosis of CKD is unclear, but it might have a renoprotective effect in hyperuricemic patients with CKD.
Journal ArticleDOI

Association between asymptomatic hyperuricemia and new-onset chronic kidney disease in Japanese male workers: A long-term retrospective cohort study

TL;DR: The results of this study suggest that asymptomatic hyperuricemia is a predictive factor for new-onset CKD for Japanese male workers.
Journal ArticleDOI

Low-grade endotoxemia contributes to chronic inflammation in hemodialysis patients: examination with a novel lipopolysaccharide detection method.

TL;DR: A significant relationship between LPS and CRP is revealed using the novel ESP method, and it is suggested that very low‐grade endotoxemia is contributing to systemic inflammation in HD patients.